Symptoms, Mimics, and Diagnostic Testing
At a Glance
RBP4-related retinal dystrophy is a rare inherited condition that can cause severe night blindness and shrinking side vision. Diagnosis combines eye examinations with retinol, RBP4, inflammation, and genetic testing while ruling out acquired vitamin A deficiency.
Identifying a retinol transport defect involves looking at both the physical state of your eyes and the biochemical makeup of your blood. Because this condition is so rare, the diagnostic process often feels like a puzzle where doctors must distinguish between a genetic “delivery” problem and an acquired “supply” shortage [1][2].
Recognizing the Symptoms
The hallmark of this condition is a chronic lack of Vitamin A reaching the retina, which can lead to several distinct symptoms:
- Night Blindness (Nyctalopia): This is often the earliest sign. You may find it extremely difficult to see in dim light or navigate at night, far beyond what is considered normal [3][4].
- Visual Field Loss: Over time, your side vision may begin to fade, creating a “tunnel vision” effect. This happens because the light-sensing cells in the retina (photoreceptors) are gradually breaking down [3][5].
- Retinal Changes: When a specialist looks at the back of your eye (the fundus), they may see specific patterns. Some patients show white-dot retinopathy, where tiny white flecks appear across the retina [6]. Others may show signs of atypical retinitis pigmentosa, characterized by pigment clumps and thinning of the retinal tissue [3][4].
The Diagnostic Pitfall: Genetic vs. Acquired Deficiency
A critical challenge in diagnosing this condition is that acquired Vitamin A deficiency can look exactly like the genetic transport defect [2]. In the acquired version, your eyes are starved for Vitamin A because your body isn’t getting enough from food or cannot absorb it [7].
Doctors must rule out these common causes of acquired deficiency before confirming a genetic transport defect:
- Malabsorption: Conditions like Celiac disease, Crohn’s disease, or chronic pancreatitis [2].
- Surgery: Previous bariatric (weight loss) or intestinal surgeries that change how you absorb nutrients [8].
- Liver Disease: Since the liver stores Vitamin A, advanced liver disease or fibrosis can disrupt the supply [2].
- Dietary Habits: A history of a very restricted or poor-quality diet [7].
Do not attempt to test yourself by taking high doses of Vitamin A. A clinical evaluation is required to interpret how your eyes respond to any intervention safely [9]. In the genetic RBP4 defect, the transport system is impaired, meaning standard supplementation requires specialized monitoring [6][9].
Essential Blood and Eye Testing
To confirm the diagnosis, your medical team will use a combination of specialized tests:
Blood Biochemistry
- Serum Retinol: This measures the amount of Vitamin A in your blood. In people with this transport defect, retinol levels are often extremely low or even undetectable, though levels can be influenced by diet or liver function [6][6].
- Serum RBP4: This measures the transport protein itself. In biallelic cases (where both copies of the gene are affected), the RBP4 protein is often severely diminished or absent [6][10].
- Inflammation Markers: Tests like CRP (C-reactive protein) are often run simultaneously because inflammation can temporarily lower your RBP4 and Vitamin A levels, which could lead to a false diagnosis [11][12].
Eye Imaging and Function
- Electroretinography (ERG): This test measures the electrical response of your retinal cells to light. It acts like an EKG for the eye and can show how much the rods and cones are struggling [5][13].
- Optical Coherence Tomography (OCT): This is a non-invasive imaging test that takes cross-section pictures of your retina. It allows doctors to see if the layers of the retina are thinning [14][13].
- Visual Field Testing: This maps your peripheral vision to determine the extent of any “blind spots” or constriction [13].
Genetic Testing
Ultimately, Next-Generation Sequencing (NGS) is heavily relied upon for diagnosis [1]. By sequencing the RBP4 gene, doctors can identify the specific mutations [4]. However, simply finding variants is not enough. The variants must be classified as pathogenic (disease-causing). If two variants are found, doctors often need to perform “segregation testing” (testing your parents) to confirm the variants are in trans (one on each chromosome). A variant of uncertain significance (VUS) alone is not diagnostic, which is why genetic results must be correlated with your bloodwork and eye exams [10].
Common questions in this guide
What are the first symptoms of RBP4-related retinal dystrophy?
How can doctors distinguish a genetic RBP4 defect from acquired vitamin A deficiency?
What do low retinol and RBP4 blood levels mean?
Which eye tests are used to evaluate RBP4-related retinal dystrophy?
Does finding an RBP4 gene variant confirm the diagnosis?
Is it safe to take high-dose vitamin A to test for an RBP4 transport defect?
Get notified when new evidence is published on Progressive retinal dystrophy due to retinol transport defect.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Vitamin A deficiency due to bi-allelic mutation of RBP4: There's more to it than meets the eye.
Khan KN, Carss K, Raymond FL, et al.
Ophthalmic genetics 2017; (38(5)):465-466 doi:10.1080/13816810.2016.1227453.
PMID: 27892788 - 2
Characteristics of Vitamin A Deficiency Retinopathy at a Tertiary Referral Center in the United States.
Levine DA, Mathew NE, Jung EH, et al.
Ophthalmology. Retina 2024; (8(2)):126-136 doi:10.1016/j.oret.2023.08.021.
PMID: 37673395 - 3
A novel homozygous c.67C>T variant in retinol binding protein 4 (RBP4) associated with retinitis pigmentosa and childhood acne vulgaris.
Cehajic-Kapetanovic J, Jasani KM, Shanks M, et al.
Ophthalmic genetics 2020; (41(3)):288-292 doi:10.1080/13816810.2020.1755985.
PMID: 32323592 - 4
RBP4-related eye disease in a Danish family with retinitis pigmentosa and congenital ocular malformations.
Kessel L, Bertelsen M, Grønskov K
Ophthalmic genetics 2022; (43(6)):876-881 doi:10.1080/13816810.2022.2141789.
PMID: 36317196 - 5
Severe ocular phenotypes in Rbp4-deficient mice in the C57BL/6 genetic background.
Shen J, Shi D, Suzuki T, et al.
Laboratory investigation; a journal of technical methods and pathology 2016; (96(6)):680-91 doi:10.1038/labinvest.2016.39.
PMID: 26974396 - 6
Large Benefit from Simple Things: High-Dose Vitamin A Improves RBP4-Related Retinal Dystrophy.
Smirnov VM, Wilmet B, Nassisi M, et al.
International journal of molecular sciences 2022; (23(12)) doi:10.3390/ijms23126590.
PMID: 35743034 - 7
Vitamin A deficiency retinopathy in the setting of celiac disease and liver fibrosis.
Pereira A, Wright T, Weisbrod D, Ballios BG
Documenta ophthalmologica. Advances in ophthalmology 2024; (149(2)):125-131 doi:10.1007/s10633-024-09978-7.
PMID: 38825634 - 8
DISRUPTION OF THE OUTER SEGMENTS OF THE PHOTORECEPTORS ON OPTICAL COHERENCE TOMOGRAPHY AS A FEATURE OF VITAMIN A DEFICIENCY.
Jevnikar K, Šuštar M, Kozjek NR, et al.
Retinal cases & brief reports 2022; (16(5)):658-662 doi:10.1097/ICB.0000000000001060.
PMID: 33181799 - 9
Retinoid Homeostasis and Beyond: How Retinol Binding Protein 4 Contributes to Health and Disease.
Steinhoff JS, Lass A, Schupp M
Nutrients 2022; (14(6)) doi:10.3390/nu14061236.
PMID: 35334893 - 10
Clinical, genetic and biochemical signatures of RBP4-related ocular malformations.
Plaisancié J, Martinovic J, Chesneau B, et al.
Journal of medical genetics 2023; (61(1)):84-92 doi:10.1136/jmg-2023-109331.
PMID: 37586836 - 11
Vitamin A biomarkers were associated with α(1)-acid glycoprotein and C-reactive protein over the course of a human norovirus challenge infection.
Victor CP, Leon JS, Williams AM
The British journal of nutrition 2024; (131(3)):482-488 doi:10.1017/S0007114523002076.
PMID: 37694547 - 12
Biomarkers of Nutrition for Development (BOND)-Vitamin A Review.
Tanumihardjo SA, Russell RM, Stephensen CB, et al.
The Journal of nutrition 2016; (146(9)):1816S-48S doi:10.3945/jn.115.229708.
PMID: 27511929 - 13
Progressive Retinal and Neurologic Findings in a Family With Neuropathy, Ataxia, and Retinitis Pigmentosa Syndrome.
Naveed F, Al-Burak SA, Hashemi E, et al.
Journal of vitreoretinal diseases 2026; 24741264261463171 doi:10.1177/24741264261463171.
PMID: 42434150 - 14
Multimodal Imaging Study of Patients With Vitamin A Deficiency Retinopathy.
Pichi F, Aljneibi S, Neri P, et al.
Ophthalmic surgery, lasers & imaging retina 2023; (54(6)):330-336 doi:10.3928/23258160-20230513-01.
PMID: 37352397
This page is for informational purposes only and does not constitute medical advice. An ophthalmologist and genetics team should interpret your eye exams, blood tests, and genetic results.